23andMe Investor Day Presentation Deck slide image

23andMe Investor Day Presentation Deck

Therapeutics Program Overview Kenneth Hillan, M.B., Ch.B. Head of Therapeutics Copyright © 2022 23andMe, Inc. 23andMe 10
View entire presentation